By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Zelluna ASA – Mandatory notification of trade
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Health > Zelluna ASA – Mandatory notification of trade
Zelluna ASA – Mandatory notification of trade
Health

Zelluna ASA – Mandatory notification of trade

GlobeNews Wire
Last updated: 08/12/2025 11:36 PM
GlobeNews Wire
Published: 08/12/2025
Share
SHARE

Reference is made to the private placement (the “Private Placement“) and the retail offering through PrimaryBid announced by Zelluna ASA on 3 November 2025. Please see the attached PDMR-form related to share lending to facilitate settlement of listed shares in tranche 2 of the Private Placement.

Attachment

  • PDMR attachment
MSP Recovery Law Firm Files Class Action Lawsuit Against Ralph Navarro and FYI Yachts for Alleged Fraud, Racketeering, and Consumer Abuse
Deltek Unveils Intelligent Platform Innovations that Elevate the Project Lifecycle
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Third Quarter Ended September 30, 2025
ChainUp’s “The ATH Night”: Singapore’s Must-Attend Pre-TOKEN2049 Networking for Digital Asset Leaders
Maldives and Henley & Partners Sign Landmark Partnership Agreement to Launch Pioneering Residence by Investment Program
TAGGED:AdventureasamandatorynewsNO0013524942notificationOslo:ZLAtradezelluna
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
IMAAVY (nipocalimab)shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)
Health

IMAAVY (nipocalimab)shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)

GlobeNews Wire
GlobeNews Wire
23/04/2026
EICMA 2025: A RECORD-BREAKING EDITION, COMBINING PASSION, BUSINESS, NEW CONTENT, AND NEW WAYS TO GET TO THE SHOW
New IBM Study Finds CIOs and CTOs Face Growing AI Control Gap as Enterprise Deployment Scales
ACKO’s Grand Traffic Challan Report: Delhi Leads E Challan Fines
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcytes 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?